GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Stanford's 2026 AI Index covers 400+ pages of data. Here's what search professionals should take from the adoption numbers, ...

A study on visual language models explores how shared semantic frameworks improve image–text understanding across ...

OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company ...

Manycore Tech debuts on Hong Kong's stock exchange today, following a $130 million IPO—and contributing to the Chinese city's ...

AI marketing platform, strong data moat, expanding margins & 20%+ growth. Click here to read my latest analysis.

Anthropic launched Claude Design, an AI tool that turns text prompts into interactive prototypes, alongside its most powerful ...

D2D services are at risk of becoming too complicated for MNOs, enterprises and government entities, and this is the best way to solve the problem.

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...

SpaceX, the Musk-led rocket and satellite maker, accounted for 1,279 — or more than 18% — of the 7,071 Cybertrucks registered ...

Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...